netFormulary South Staffordshire and Shropshire Healthcare NHS
NHS Foundation Trust  
 Introduction

Welcome to the SSSFT formulary

Useful Links

 

 

 

Choice & Medication

 

 

NICE

 

 

MHRA

 

 

Yellow Card Scheme

 

 

Application to Amend Formulary

 

 

South Staffordshire Joint Formulary (including the Antimicrobial Prescribing Guidelines in General Practice

 

 

Essential Shared Care Agreements (ESCAs)

 

 

High Risk Drugs List

 

 

Patient Group Directions (PGDs)

 

 

Telford & Wrekin CCG Formulary

 

 

 Individual Patient Request for a Non-Formulary Drug

 

 

Pharmacy

Shropshire CCG Formulary Paliperidone 3 monthly LAI Referral Form

 

 

News Feed
MOC Prescribing Notification: Valproatge and Females of Childbearing Potential
MOC Prescribing Notification: The Impact that a Change in Smoking Habit can have on Prescribed Medication
MOC Prescribing Notification: Alterations to the BNF & SPC for Holoperidol
MOC Prescribing Notification: Rapid Tranquilisation Policy Amendments
MOC Prescribing Notification: Antibiotic Prescribing Practice
Hot Topics Dec 17
>>> more news

Introduction

The Formulary has been developed by the Medicines Optimisation Committee (MOC) of South Staffordshire & Shropshire Healthcare NHS Foundation Trust and through consultation with clinicians.  Details of the MOC membership can be found on the Trusts Internet at http://www.sssft.nhs.uk/services/pharmacy.  The Formulary represents a collaborative approach to medicines optimisation between the Trust and its key Primary Care Partners

The Aim of the Formulary is to advise clinicians on evidence based drug treatments (which are cost and clinically effective) and commonly encountered in clinical practice.

The Formulary is applicable to all doctors and all Non-Medical Prescribers (NMPs) whose individual Formularies will be agreed with the Advanced Nurse, Medicines Optimisation, the NMP and their Designated Medical Practitioner.

The vast majority of prescribing in Mental Health both in primary and secondary care should be covered by this Formulary.  The Formulary advises on the appropriate positioning of drugs in the treatment of mental health conditions.  Compliance rates with the Formulary are fed back at Team level to Clinical Directorates on a regular basis.  On the rare occasions when In Patient clinicians are required to initiate physical health medicines please refer to the appropriate primary care Formulary which can be found at the following web addresses: http://www.southstaffordshirejointformulary.nhs.uk/, http://www.telfordccg.nhs.uk/primary-care-drugs-formulary-, http://www.shropshireccg.nhs.uk/drug-formulary.

All drugs should be prescribed generically unless a particular preparation needs to be specified because of variations in bioavailability between different brands, these are identified in the Formulary.  It is recognised that on occasion non-formulary items will be legitimately requested although in such circumstances Pharmacists may seek a rationale from the prescribing clinicians.  Licensed products should be used wherever possible.

It is anticipated that this Formulary will evolve through debate and suggestion and as new drugs become available.  Requests for amendments to the formulary can only be made by psychiatrists and should be made by submitting the Application to Amend the Formulary Form which can be accessed from either the netFormulary or at the following web page: http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/formulary.  Genuine ownership of the Formulary by clinicians in the Trust who prescribe for people with mental health problems will help to refine it and enhance its relevance to everyday clinical practice.

A price banding system has been included; the aim of the banding is to give the prescribing clinician an idea of the cost.  The costs have been calculated using the May 16 Drug Tariff prices with the exception of the Inclusion section which uses the December 17 Drug Tariff prices (the cost to primary care).  Prices are for oral, immediate release preparations, 28 days supply at the highest BNF dose.  Clinicians should note from this information that differences between formulations of the same drug can be significant as medicines come off Patent e.g. XL formulations, patches, orodispersible products

Each drug has been colour coded: green means any clinician can prescribe, amber means it is appropriate for all clinicians but must be initiated by a specialist and the patient stabilised before shared care is considered & red means specialist services only.

Essential Shared Care Agreements or Best Practice Guidelines have been agreed for deployment in certain areas, they can be found on netFormulary or the Trusts website at http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/essential-shared-care-agreements-escas.

The National Patient Safety Agency has published a Reduction of Self Harm and High Risk Drugs, which can be found on the Trusts website at: http://www.sssft.nhs.uk/services/pharmacy/information-for-professionals/high-risk-drugs-list.

The Royal College of General Practitioners and Secure Environments Pharmacists Group have published guidance on Safer Prescribing in Prison, which can be found at http://www.rcgp.org.uk/clinical-and-research/clinical-resources/~/media/106D28C849364D4CB2CB5A75A4E0849F.ashx.




NetFormulary
   Visits = 11760
   Last updated: 27/09/2018 14:55:38